| Title |
Production and manufacturing of biosimilar insulins: implications for patients, physicians, and health care systems
|
|---|---|
| Published in |
Biosimilars, November 2014
|
| DOI | 10.2147/bs.s36043 |
| Authors |
Martin Kuhlmann, Andrea Schmidt |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 96 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 15 | 16% |
| Student > Bachelor | 14 | 15% |
| Researcher | 10 | 10% |
| Student > Ph. D. Student | 5 | 5% |
| Other | 4 | 4% |
| Other | 11 | 11% |
| Unknown | 37 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 17 | 18% |
| Biochemistry, Genetics and Molecular Biology | 16 | 17% |
| Agricultural and Biological Sciences | 10 | 10% |
| Medicine and Dentistry | 4 | 4% |
| Chemical Engineering | 3 | 3% |
| Other | 8 | 8% |
| Unknown | 38 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2021.
All research outputs
#8,618,268
of 25,582,611 outputs
Outputs from Biosimilars
#6
of 25 outputs
Outputs of similar age
#92,054
of 274,218 outputs
Outputs of similar age from Biosimilars
#2
of 2 outputs
Altmetric has tracked 25,582,611 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 25 research outputs from this source. They receive a mean Attention Score of 1.9. This one scored the same or higher as 19 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,218 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.